(Q34229211)

31 July 2017

1 reference

title

Therapeutic drug monitoring in methadone maintenance: choosing a matrix (English)

1 reference

31 July 2017

Moolchan ET

1

1 reference

31 July 2017

Umbricht A

series ordinal

2

1 reference

31 July 2017

Epstein D

series ordinal

3

1 reference

31 July 2017

publication date

1 January 2001

1 reference

Journal of Addictive Diseases

31 July 2017

published in

1 reference

31 July 2017

volume

20

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

55-73

1 reference

Steady-state pharmacokinetics of methadone in opioid addicts

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

The pharmacokinetics of methadone in healthy subjects and opiate users

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Methadone plasma level: sustained by a reservoir of drug in tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Methadone maintenance: optimizing dosage by estimating plasma level

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Ultrafiltration using the Amicon MPS-1 for assessing methadone plasma protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Rifampin-Induced Methadone Withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Craving despite extremely high methadone dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

The effect of fluconazole on the clinical pharmacokinetics of methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Fluvoxamine-methadone interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Cocaine Abuse in Methadone Maintenance Patients Is Associated with Low Serum Methadone Concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Alcohol and opioids: possible interactions of clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Medical complications in methadone patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Alterations in methadone metabolism during late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Pharmacokinetics of methadone in methadone maintenance treatment: characterization of therapeutic failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Detection of drug use in a methadone maintenance clinic: sweat patches versus urine testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Therapeutic Drug Monitoring in Saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

A method for the confirmation and identification of drugs of misuse in urine using solid phase extraction and gas-liquid chromatography with mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Diazepam and methadone blood levels following concurrent administration of diazepam and methadone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Adolescent heroin use: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Replacement of (R)-methadone by a double dose of (R, S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

Fluoxetine Addition to Methadone in Addicts: Pharmacokinetic Aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V20N02_05

21 January 2018

Identifiers

DOI

10.1300/J069V20N02_05

1 reference

31 July 2017

1 reference